Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
La Radiologia Medica|March 21, 2025
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteriaCharlotte Trombadori, Edda Boccia, Elena Huong Tran, et al.
Cancers|March 28, 2025
Oncological Safety of Prepectoral Implant-Based Breast Reconstruction After Conservative Mastectomy: Insights from 842 Consecutive Breast Cancer PatientsLorenzo Scardina, Alba Di Leone, Alejandro Martin Sanchez, et al.
Annals of Surgical Oncology|March 12, 2026
Axillary Nodal Positivity in Early-Stage Invasive Lobular Carcinoma: Implications for Sentinel Lymph Node Biopsy OmissionLorenzo Scardina, Sabatino D'Archi, Cristina Accetta, et al.
Cancers|March 10, 2022
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center ExperienceAlba Di Leone, Antonio Franco, Daniela Andreina Terribile, et al.
Surgery|May 28, 2026
De-escalating axillary surgery in ductal carcinoma in situ undergoing mastectomy with immediate reconstruction: Is routine sentinel lymph node biopsy an overtreatment?Lorenzo Scardina, Sabatino D'Archi, Cristina Accetta, et al.
Journal of Personalized Medicine|August 29, 2024
Outcomes of Radiotherapy in Oligoprogressive Breast CancerFabio Marazzi, Valeria Masiello, Armando Orlandi, et al.
Journal of Personalized Medicine|March 6, 2021
The Assisi Think Tank Meeting Breast Large Database for Standardized Data Collection in Breast Cancer-ATTM.BLADEFabio Marazzi, Valeria Masiello, Carlotta Masciocchi, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2025
Simultaneous integrated boost intensity-modulated radiotherapy for treatment of bone metastases: analysis of a breast cancer cohortFabio Marazzi, Valeria Masiello, Alessandra Fabi, et al.
Journal of Personalized Medicine|August 25, 2023
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant ChemotherapyAntonio Franco, Alba Di Leone, Marco Conti, et al.
NPJ Breast Cancer|September 8, 2023
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancerAlessandra Fabi, Luisa Carbognin, Andrea Botticelli, et al.
Pageof 9